|Last Price$5.84||Day Change (%)-0.68%|
|Open Price$5.85||Day Change ($)-0.04|
|Day Range5.74–5.93||52-Week Range1.84–6.65|
As of Fri 5/22/2015 5:00:00 PM | USD
Research and Markets: Global Pituitary ACTH Hypersecretion (Cushing's Disease) Pipeline Report 2015 - 9 Companies & 16 Drug Profiles
Cortendo AB: Cortendo Adds Two Late-Stage Assets to Its Rare Endocrine Disease Franchise and Announces Related $33.2 Million Financing
Cortendo AB: Cortendo and Antisense Therapeutics Announce Licensing Agreement for ATL1103 for Acromegaly
With "massive" student debt loads receding in the rearview mirror, a young professional couple fires up their investment plan.
Berkshire's non-insurance operations continue to be an added source of stability while reinsurance operations continue to struggle.
Wide-moat Berkshire Hathaway saw solid top-line results from each of its main segments, but losses from investments, derivatives, and eliminations sent earnings lower.
Noninsurance operations continue to be a source of stability, while its insurance business overall may see more meager results during the next couple of years.
Just about every segment at Berkshire was dealing with elevated costs during the first quarter.
Morningstar's Gregg Warren says Berkshire's sterling balance sheet, strong business, and unique structure will sustain the firm's competitive standing--even without Buffett.